TWEAK-stimulated macrophages inhibit metastasis of epithelial ovarian cancer via exosomal shuttling of microRNA

Cancer Letters

Volumn 393, Issue , 2017, Pages 60-67

  Hu, Yuan ^a,b   Li, Dong ^a,b   Wu, Anyue ^a,b   Qiu, Xingdi ^a,b   Di, Wen ^a,b   Huang, Lei ^a   Qiu, Lihua ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Key Laboratory of Gynecologic Oncology   (China)

Author keywords

Epithelial ovarian cancer; Exosomes; Macrophages; Metastasis; MiR 7; TWEAK

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MICRORNA; MICRORNA 7; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; TUMOR NECROSIS FACTOR; TWEAK PROTEIN; UNCLASSIFIED DRUG; ANTAGOMIR; EGFR PROTEIN, HUMAN; MIRN7 MICRORNA, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOMA CELL; CELL INVASION; CELL MIGRATION; CELLULAR SECRETION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EXOSOME; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTERNALIZATION; MACROPHAGE; METASTASIS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OVARY CARCINOMA; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; TUMOR XENOGRAFT; WESTERN BLOTTING; ANIMAL; CELL MOTION; COCULTURE; DNA MICROARRAY; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENETICS; MACROPHAGE ACTIVATION; METABOLISM; NEOPLASM; NUDE MOUSE; OVARY TUMOR; PARACRINE SIGNALING; PATHOLOGY; PROCEDURES; SECONDARY; SIGNAL TRANSDUCTION; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; ANTAGOMIRS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL MOVEMENT; COCULTURE TECHNIQUES; EXOSOMES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MACROPHAGE ACTIVATION; MACROPHAGES; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; PARACRINE COMMUNICATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR NECROSIS FACTORS;

EID: 85014008862     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2017.02.009     Document Type: Article

References (28)

1. [1] Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2016. CA Cancer J. Clin. 66 (2016), 7–30.
2. [2] Jelovac, D., Armstrong, D.K., Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J. Clin. 61 (2011), 183–203.
3. [3] Qian, B.Z., Pollard, J.W., Macrophage diversity enhances tumor progression and metastasis. Cell 141 (2010), 39–51.
4. [4] Robinson-Smith, T.M., Isaacsohn, I., Mercer, C.A., Zhou, M., Van Rooijen, N., Husseinzadeh, N., et al. Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice. Cancer Res. 67 (2007), 5708–5716.
5. [5] Salido-Guadarrama, I., Romero-Cordoba, S., Peralta-Zaragoza, O., Hidalgo-Miranda, A., Rodriguez-Dorantes, M., MicroRNAs transported by exosomes in body fluids as mediators of intercellular communication in cancer. OncoTargets Ther. 7 (2014), 1327–1338.
6. [6] Wang, J., Yao, Y., Wu, J., Li, G., Identification and analysis of exosomes secreted from macrophages extracted by different methods. Int. J. Clin. Exp. Pathol. 8 (2015), 6135–6142.
7. [7] Cocucci, E., Racchetti, G., Meldolesi, J., Shedding microvesicles: artefacts no more. Trends Cell Biol. 19 (2009), 43–51.
8. [8] Dreyer, F., Baur, A., Biogenesis and functions of exosomes and extracellular vesicles. Methods Mol. Biol. 1448 (2016), 201–216.
9. [9] Chicheportiche, Y., Bourdon, P.R., Xu, H., Hsu, Y.M., Scott, H., Hession, C., et al. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem. 272 (1997), 32401–32410.
10. [10] Maecker, H., Varfolomeev, E., Kischkel, F., Lawrence, D., LeBlanc, H., Lee, W., et al. TWEAK attenuates the transition from innate to adaptive immunity. Cell 123 (2005), 931–944.
11. [11] Kaduka, Y., Takeda, K., Nakayama, M., Kinoshita, K., Yagita, H., Okumura, K., TWEAK mediates anti-tumor effect of tumor-infiltrating macrophage. Biochem. Biophys. Res. Commun. 331 (2005), 384–390.
12. [12] Gu, L., Dai, L., Cao, C., Zhu, J., Ding, C., Xu, H.B., et al. Functional expression of TWEAK and the receptor Fn14 in human malignant ovarian tumors: possible implication for ovarian tumor intervention. PLoS One, 8, 2013, e57436.
13. [13] Huh, H.Y., Pearce, S.F., Yesner, L.M., Schindler, J.L., Silverstein, R.L., Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. Blood 87 (1996), 2020–2028.
14. [14] Andreesen, R., Osterholz, J., Bodemann, H., Bross, K.J., Costabel, U., Lohr, G.W., Expression of transferrin receptors and intracellular ferritin during terminal differentiation of human monocytes. Blut 49 (1984), 195–202.
15. [15] Steinbach, F., Thiele, B., Phenotypic investigation of mononuclear phagocytes by flow cytometry. J. Immunol. Methods 174 (1994), 109–122.
16. [16] Kosaka, N., Iguchi, H., Yoshioka, Y., Takeshita, F., Matsuki, Y., Ochiya, T., Secretory mechanisms and intercellular transfer of microRNAs in living cells. J. Biol. Chem. 285 (2010), 17442–17452.
17. [17] Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319 (2008), 1244–1247.
18. [18] Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J.J., Lotvall, J.O., Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9 (2007), 654–659.
19. [19] Zhou, X., Hu, Y., Dai, L., Wang, Y., Zhou, J., Wang, W., et al. MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer. PLoS One, 9, 2014, e96718.
20. [20] Zhou, W., Fong, M.Y., Min, Y., Somlo, G., Liu, L., Palomares, M.R., et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell 25 (2014), 501–515.
21. [21] Ying, X., Wu, Q., Wu, X., Zhu, Q., Wang, X., Jiang, L., et al. Epithelial ovarian cancer-secreted exosomal miR-222-3p induces polarization of tumor-associated macrophages. Oncotarget, 2016.
22. [22] Kong, X., Li, G., Yuan, Y., He, Y., Wu, X., Zhang, W., et al. MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression. PLoS One, 7, 2012, e41523.
23. [23] Chan, L.W., Wang, F.F., Cho, W.C., Genomic sequence analysis of EGFR regulation by microRNAs in lung cancer. Curr. Top. Med. Chem. 12 (2012), 920–926.
24. [24] Liu, Z., Jiang, Z., Huang, J., Huang, S., Li, Y., Yu, S., et al. miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways. Int. J. Oncol. 44 (2014), 1571–1580.
25. [25] Qiu, L., Zhou, C., Sun, Y., Di, W., Scheffler, E., Healey, S., et al. Crosstalk between EGFR and TrkB enhances ovarian cancer cell migration and proliferation. Int. J. Oncol. 29 (2006), 1003–1011.
26. [26] Guo, T., Zhao, L., Zhang, Y., Liu, G., Yao, Y., Li, H., A monoclonal antibody targeting the dimer interface of epidermal growth factor receptor (EGFR). Immunol. Lett., 2016.
27. [27] Cao, C., Lu, S., Sowa, A., Kivlin, R., Amaral, A., Chu, W., et al. Priming with EGFR tyrosine kinase inhibitor and EGF sensitizes ovarian cancer cells to respond to chemotherapeutical drugs. Cancer Lett. 266 (2008), 249–262.
28. [28] Higuchi, T., Todaka, H., Sugiyama, Y., Ono, M., Tamaki, N., Hatano, E., et al. Suppression of MicroRNA-7 (miR-7) biogenesis by nuclear factor 90-nuclear factor 45 complex (NF90-NF45) controls cell proliferation in hepatocellular carcinoma. J. Biol. Chem. 291 (2016), 21074–21084.